4//SEC Filing
Flynn Daniel Lee 4
Accession 0001209191-22-011360
CIK 0001654151other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 5:01 PM ET
Size
10.6 KB
Accession
0001209191-22-011360
Insider Transaction Report
Form 4
Flynn Daniel Lee
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-02-16$9.05/sh−1,366$12,362→ 47,866 total
Holdings
- 230,435(indirect: By Trust)
Common Stock
- 91,020(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001713712
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 5:01 PM ET
- Size
- 10.6 KB